Form 4: Clorox Director Boosts Stake with Deferred Stock Units

Clorox Co. Director Stephanie Plaines increased her beneficial ownership of the company's stock through the acquisition of Deferred Stock Units.

Summary

• Clorox Co. Director Stephanie Plaines acquired a total of 1,973.7514 Deferred Stock Units (DSUs) through three separate transactions.
• On November 6, 2025, 63.1574 DSUs were acquired through dividend reinvestment as part of the Independent Directors' Deferred Compensation Plan.
• On December 31, 2025, an annual award resulted in the acquisition of 1,637.8577 DSUs under the 2005 Stock Incentive Plan.
• Also on December 31, 2025, an additional 272.7363 DSUs were received in lieu of quarterly director's fees.
• Following these transactions, Stephanie Plaines beneficially owns a total of 7,386.9498 Deferred Stock Units.
• These DSUs will be settled 100% in Clorox common stock upon the reporting person's retirement or other termination of service as a Director.

Sentiment

Score: 6

Explanation: The sentiment is slightly positive as a director is increasing their stake in the company, which generally signals confidence and aligns their interests with shareholders. However, these are routine acquisitions through compensation plans rather than open market purchases, limiting the strength of the positive signal.

Positives

• A director increased their beneficial ownership in the company, aligning their interests more closely with those of shareholders.
• The acquisitions were made through established compensation and dividend reinvestment plans, indicating routine and structured equity accumulation.

Future Outlook

The Deferred Stock Units are scheduled to be settled entirely in Clorox common stock upon the reporting person's retirement or termination of service as a Director.

Industry Context

This filing reflects a routine insider transaction for a director of a consumer goods company, consistent with standard executive compensation practices that often include equity awards and dividend reinvestment to align management incentives with long-term shareholder value.

Stakeholder Impact

• Shareholders: Increased alignment of the director's financial interests with those of the company's shareholders due to higher equity ownership.

Next Steps

• The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.

Key Dates

Recommendation

This Form 4 details routine acquisitions of Deferred Stock Units by a director as part of compensation and dividend reinvestment plans. While it indicates continued alignment of management interests with shareholders, it does not present new fundamental information or significant market-moving events to warrant a change from an existing investment thesis. Therefore, a 'hold' recommendation is appropriate, as the filing reinforces existing confidence without providing a catalyst for a stronger action.

Keywords

Clorox, CLX, Form 4, insider transaction, beneficial ownership, deferred stock units, director compensation, equity acquisition, dividend reinvestment